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                              ABSTRACT  
Purpose of the Project: 
   This study intends to evaluate the usefulness of 
sequential organ failure assessment score (SOFA) in assessing 
organ dysfunction and risk of mortality in patients admitted to 
ICU. 
Background: 
  Outcome prediction is important in both clinical and 
administrative ICU management. It can be usefully applied to 
monitor the progress of an individual ICU. It also provides 
useful information on likely patient outcomes for critically ill 
patients and also for therapeutic decision making and using 
available resources efficiently. In an ICU setting serial organ 
function monitoring is important since there is a time to time 
variation in the general condition of the patient. Sequential 
Organ Failure Assessment (SOFA) is one such outcome 
prediction model to assess prognosis and mortality risk in ICU 
patients. 
Data Collection and the Source: 
  All adult patients admitted to the intensive care unit 
of Coimbatore Medical College Hospital will be included in the 
study. Blood samples will be collected from the patients 
admitted to the ICU for the investigations as per the data needed 
by the SOFA scoring system. Along with these, blood pressure 
monitoring and Glasgow coma scale evaluation will be done on 
admission and then for every 48 hrs, for six days or till the 
patient leaves the ICU either as survivor or non survivor, 
whichever occurs earlier. 
Sampling method: 
  Prospective observational cohort study. 
Case definition: 
  Patients admitted to the ICU with suspected multi 
organ failure. 
 
 
Results: 
  The age group in this study ranges from 17 to 85. 
The study shows that above the SOFA score value of 12, there is 
a sharp increase in mortality rate. More than 85% of the non 
survivors had an increase in their SOFA scores during their stay 
in ICU. Admission SOFA and mean sofa are excellent 
predictors of mortality. Total SOFA provides information about 
severity of organ failure. Mechanically ventilated patients had a 
higher mortality rate compared to non ventilated patients. 
Presence of diabetes and hypertension did not show any 
significant association with mortality in our study. 
Conclusion:  
  A rise in SOFA score is a strong predictor of 
mortality in ICU patients. 
Key words: SOFA – sequential organ failure assessment. ICU – 
Intensive care unit. 
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                                      INTRODUCTION 
Intensive care unit is a place in which critically ill patients are managed. 
These patients suffer morbidity and mortality to a large extent due to their 
complicated nature of illness. In most of the ICU patients more than one 
organ system is involved. This makes the management even more 
challenging. So prediction of prognosis becomes important in these 
patients. The idea behind this strategy is, to give a reliable outcome of the 
disease process, to the relatives of the patient. This helps in resolving 
unnecessary conflicts between the health care personnel and the patient 
relatives. Next important thing is, as to decide to which patient, the 
available resources need to be utilised.  
This led to the idea of devising scoring systems. These systems guide the 
efficient utilisation of ICU resources, especially in a resource starved 
setting. This helps in preventing dumping of valuable drugs and treatment 
modalities in a patient, who may not survive in spite of all efforts. On the 
contrary they can be utilised for a person, who may improve well with 
such costly intervention. 
Sequential organ failure assessment called the SOFA scoring system is a 
simple scoring system calculated using easily available basic 
investigations, to predict outcome, especially mortality in ICU patients. 
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This study was undertaken to evaluate the score among ICU patients in 
Coimbatore medical college hospital admitted with various systemic 
illness and features of multi organ dysfunction.         
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                                     AIMS OF THE STUDY 
• To study the usefulness of sequential organ failure assessment 
score in predicting mortality among ICU patients. 
• To study the impact of comorbid illnesses like diabetes and 
hypertension on outcome, in ICU patients in relation to SOFA 
score. 
• To study the mortality among mechanically ventilated patients and 
its correlation with SOFA score. 
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                            REVIEW OF LITERATURE 
I would especially commend the physician who, in acute diseases, 
by which the bulk of mankind are cut off, conducts the treatment better 
than others. 
- Hippocrates  
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ICU and Critical care:  
The management of critically ill patients admitted to the intensive 
care units are becoming more and more challenging due to emergence of 
new diseases day by day, the combination of various illness and the 
increased life expectancy of population due to advanced medical care. 
New treatment protocols are being formulated and older treatment 
protocols are revised periodically for patient management and care in an 
ICU setting, from the previous experiences and with the help of newer 
drugs coming up every day. An ICU patient is totally different from a 
patient in the general ward, right from his physiology, disease 
pathogenesis, nutritional requirements, response to treatment and overall 
prognosis. This indeed makes them a population which needs special care 
in all aspects. Most of the ICU patients have more than one disease 
process which is manifested by the vital organ involvement. This gave 
rise to the concept of  multiorgan dysfunction syndrome(MODS), which 
means the abnormal function or failure of more than one organ system. 
So the standard of care for these set of population lies in proper diagnosis, 
monitoring of treatment response and  progress every day and even every 
hour to ensure proper outcome, which means survival from that illness or 
atleast not to succumb to the illness. To ensure this we need to understand 
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the nature of illness a critical care unit patient is going through, the 
pathogenesis of the disease process and its prognosis.  
In addition to their inherent disease process, a critical care unit 
patient is also more prone for nosocomial infections due to improper 
nutrition, immunodeficient states, systemic illness like diabetes, 
hypertension etc. Geriatric patients falls under an even more riskier 
group. So all these factors add fuel to the entity called multi organ 
dysfunction syndrome(MODS). 
Multi organ dysfunction syndrome: 
The abnormal function or failure of  more than one organ or organ 
system requiring medical support to maintain homeostasis  is called 
MODS. In a susceptible individual, under the influence of associated 
comorbidities, the organ systems fail one by one ultimately leading to a 
complicated disease process and death.    
Pathogenesis: 
The general principles governing the syndrome of multiorgan 
dysfunction are, 
1) Organ failure, no matter how defined, must persist beyond 24 
hours 
2) Mortality risk increases as the patients accrue additional failing 
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3) Prognosis is worsened by increased duration of organ failure. 
These observations remain true across various critical care settings all 
over the world. Systemic inflammatory response syndrome (SIRS) is the 
common basis for multi organ system failure. Infection is by far the 
commonest cause of SIRS. Though other triggers like pancreatitis, trauma 
and burns etc can also elicit a similar response. 
Systemic inflammatory response syndrome: 
It includes more than two of the following: 
1) Rise in temperature >38 degree celcius or hypothermia (<36 degree 
celcius) 
2) Tachypnoea (respiratory rate>24 /min) 
3) Heart rate  > 90/min 
4) Leukocytosis (>12 ×10
3
/microlitre), leukopenia (<4 × 10
3
/microlitre). 
Pathophysiology: 
Bacteria and fungi trigger most cases of sepsis which are less or 
not harmful to immune competent host. These organisms exploit the host 
defence mechanism to establish life threatening infections. Once these 
organisms enter the blood , the body can build up a vigorous immune 
response, that results in severe sepsis but not able to kill the organism. 
This results in what called systemic inflammatory response syndrome. 
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An ICU patient: 
A slender and restricted diet is always dangerous in chronic and in acute 
diseases. 
- Hippocrates 400 BC 
A lot of changes are produced in the metabolic milieu of a patient 
admitted in critical care. They are 
• Poor food intake 
• Prolonged bed rest 
• Changes in substrate utilization 
• Stress due to illness or surgical procedure 
• Hypermetabolism 
• Exogenous steroids 
• Immobility 
All these leads to a process termed as ‘autocannibalism’, which 
indicates the loss of lean and fat body mass. This leads to a state of 
malnutrition. 
Malnutrition can lead to the following consequences 
• Increased morbidity and mortality 
• Prolonged hospital stay 
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• Reduced respiratory and cardiac function 
• Impaired wound healing 
• Increased risk of infection due to immunosupression. 
A lot of guidelines are available on how to give nutritional support in an 
ICU patient. Some of them are 
1) National institute for health and clinical excellence(NICE): 
Nutritional support in adults (2006). 
2) European society for parenteral and enteral nutrition (ESPEN): 
Enteral nutrition (2006). 
3) Intensive care society (ICS) 2005: Practical management of 
parenteral nutrition in critically ill patients. 
4) Canadian critical care network 2003/2007: clinical practice 
guidelines. 
Nutritional requirements:  
Basal energy expenditure can be calculated for each individual by 
the Harris – Benedict equation 
For men, BEE = 66.5 + (13.75 × weight in kg) + (5.003 × height in 
cm) – (6.775 × age in years) 
For women, BEE = 655.1 + (9.563 × weight in kg) + (1.850 × 
height in cm) – (4.676 × age in years). 
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Requirements per day: 
• Energy – 25 to 30 kcal/kg 
• Water – 30 ml/kg 
• Carbohydrate – 55 to 70 % of total energy 
• Fat – 15 to 30 % of total energy 
• Protein – 10 to 15 % of total energy 
Complications of Enteral nutrition:  
1) The feeding tube can get dislodged or get blocked. 
2) Gastric hypersecretion 
3) Lactose intolerance 
4) Hyperosmolar feeding 
5) Malabsorption 
6) Altered bowel flora 
In short, all these dietary factors should be taken into consideration 
during planning of patient in an ICU. 
Some of the commonest causes of ICU admission are 
1) Systemic infections 
2) Sepsis  
3) ARDS 
4) Acute coronary syndrome 
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5) Renal failure 
6) Acute neurological illness 
7) Cancer and oncological emergencies 
Systemic infections: 
Infections were once a greatest threat to mankind. With the advent 
of antibiotics lot of  dreadful infections were brought under control. With 
the evolution of  human immune deficiency virus many new infections 
emerged and previously drug sensitive microbes became resistant. Also in 
asian countries , india especially higher prevalence of diabetes and poor 
hygienic conditions added  to a higher incidence of infections. So 
antibiotic resistant microbes are the concern of this century. Some of the 
commonest infections encountered in the ICU are 
1) Urinary tract infections and 
2) Pneumonias 
3) Meningitis  
Urinary tract infections: 
The commonest and most challenging infection in any hospitalised 
patient is UTI. It can range from simple uncomplicated infection to a 
serious life threatening  infection.  It can vary in spectrum from 
asymptomatic bacteruria to cystitis, prostatitis and pyelonephritis.  
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UTI is common in women of reproductive age group(1,2) and men after 
the age of 50 due to prostrate hypertrophy. In ICU patients the 
predisposing factor for UTI are indwelling urinary catheters, renal stones, 
abnormal micturition and significant residual urine due to inability to 
void or incomplete voiding which is common in a long term bed ridden 
patient.(3,4) 
Pathogens: 
The organisms implicated in UTI  in the order of prevalence are 
1) Escherichia coli 
2) Staphylococcus saphrophyticus 
3) Klebsiella 
4) Proteus 
5) Enterococcus 
6) Citrobacter 
7) Salmonella 
8) Candida species and other organisms 
Patient presents with or without fever with chills and rigor 
and elevated blood counts. Prompt diagnosis and management are 
essential to prevent severe life threatening infections. 
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Untreated or improperly managed UTI leads to complications like 
recurrent UTI, chronic pyelonephritis and renal insufficiency(5) 
either acute or chronic. When the infection overwhelms especially 
due a drug resistant organism this can lead to systemic sepsis ,also 
called urosepsis. 
Pneumonias: 
Patient may be admitted in an ICU for a community acquired 
pneumonia or the infection can be  nosocomial in patients admitted 
for some other illness. In either form this infection can be life 
threatening needing mechanical ventilator support.    
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Ventilator Associated Pneumonias : 
ICU patients are more prone to get lung infections especially 
pneumonia. Ventilator associated pneumonia(VAP) is common in 
patients requiring mechanical ventilation. In any given day at least 10% 
of patients will have pneumonia in an ICU. Factors responsible for VAP 
are 
1) Colonisation of oropharynx with pathogenic organism 
2) Aspiration of these orgasnisms into lower respiratory tract 
3) Impaired host defence mechanism 
Rupture of distal airspaces during mechanical ventilation due to 
overdistension is called volutrauma and pressure related lung injury is 
called barotrauma(6). This leads to infiltration of distal airspaces with 
exudative substances. This condition is called Ventilator Induced Lung 
Injury(VILI)(7). The cytokines produced in the lung could enter the 
systemic circulation and produce widespread inflammatory  injury in the 
distant organ and cause multiorgan failure(8)Morbidity and mortality is 
more common with this condition. But  patients when given adequate 
care in a high intensive ICU, mortality can be reduced(9) .  
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Meningitis: 
Types of meningitis:- 
Meningitis can be categorized according to CSF cytochemical 
picture as, neutrophilic meningitis, lymphocytic meningitis, and aseptic 
meningitis. 
Neutrophilic meningitis: 
                 The most common cause is bacterial infection. Other rare 
causes are fungal infection, nocardian infection, actinomyces infection 
etc.  
Bacterial meningitis: 
                 Acute bacterial infection of meninges causes a clinical  picture 
of acute meningitis. Also known as  bacterial meningitis, purulent 
meningitis and septic meningitis. Most often meninges , subarachnoid 
space and brain parenchyma are all involved in inflammatory reaction 
causing meningoencephalitis. 
                Currently most common organisms responsible for community 
acquired bacterial meningitis are streptococcus pneumonia, 
meningococcus, Haemophilus influenza, Group B Streptococcus  and 
Listeria monocytogenes. Neisseria meningitidis  and Streptococcus 
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pneumoniae  are the most common pathogens  in patients without 
immune deficiency. 
Streptococcus pneumoniae, is the most common cause of 
meningitis in adults above 20 years. The predisposing conditions are 
pneumonia due to pneumococcus, sinusitis, mastoiditis, otitismedia, 
choclear implants, diabetes mellitus, postsplenectomy. 
Neisseria meningitides is most common in adolescent and young 
adults(2- 20 years). The bacteria  are usually recovered from blood or 
cutaneous lesions before meningitis starts, indicating that spread to the 
CNS is hematogenous.  Occasionally it may  gain access directly from the 
nasopharynx through cribriform plate. Found in individuals with 
complement deficiency. 
In infants and children most common organisms are Streptococcus 
pneumoniae, Neisseria meningitidis, Haemophilus influenza type b. 
In infancy most common pathogens are Group B Streptococcus, 
Escherichia coli, Listeria monocytogenes is frequently reported in 
meningitis above 50 years, especially adults with chronic diseases (e.g. 
patients on haemodialysis, malignancy, connective tissue disorders). 
Staphylococci (S. aureus and S. epidermidis) and gram-negative 
bacilli are common pathogens in patients following  a neurosurgical 
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procedure. Sometimes  it is a complication of cavernous sinus 
thrombosis, subdural or epidural abscess. 
Recurrent Bacterial Meningitis signal a host defect, either in local 
anatomy or in antibacterial and immunologic defenses. 
1. Local anatomy: 
• Head trauma (floor of the anterior cranial fossa) with CSF 
rhinorrhoea 
• Head trauma(temporal bone)with access of bacteria to the CSF 
from the ear 
• In situ shunt devices for relief of hydrocephalus. 
2. General (defective immunologic defenses): 
• Diabetes mellitus 
• immune deficiency or immunosuppression. 
A pathogenesis of bacterial meningitis is inflammatory reaction 
induced by invading bacteria. Most often due elevated CSF cytokines and 
chemokines. The inflammatory reaction is severe in the subarachnoid 
space over the brain and around the cisterns (base of the brain). It may 
extend  along the perivascular spaces into the brain and spinal cord but 
rarely breaks into the parenchyma of the brain. 
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                         Pathogenesis of meningitis  
 
 
 
 
 
 
 
 
The classical clinical triad of meningitis consists of fever, 
headache, and neck rigidity. Nausea, vomiting, phonophobia, 
photophobia are usually seen. With the disease progression, the 
sensorium becomes clouded and stupor. Convulsive seizures are often an 
early symptom (20%-40% cases), especially in children. 
The temperature is elevated at 101°F to 103°F. The pulse is usually 
rapid and there is increased respiratory rate. There is nuchal rigidity, 
Kernig’s sign (resistance to extension of the legs) and Brudzinski’s signs 
(resistance to forward flexion of the neck). The above signs may be 
absent in newborn and elderly. Tendon reflexes are often decreased. 
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Cranial nerve palsies and focal neurologic deficits are uncommon and 
usually develop several days after the onset of infection. Papilloedema 
may develop if the meningitis persists for more than a week otherwise 
optic disc is normal. 
The WBC count is increased and it is usually in the range of 
10,000/mm
3
 to 30,000/mm
3
. The pressure of CSF is increased and usually 
between 200 and 500 mm H2O. The CSF is cloudy because it contains a 
numerous cells, predominantly polymorphonuclear leukocytes. The cell 
count in the CSF is usually between 2,000/mm
3
 and 10,000/mm
3
. The 
protein content of CSF  is increased. The sugar content is decreased 
(below 20 mg/dl). Particle agglutination testing  may rapidly identify 
bacterial antigens in the CSF. 
Another modality used for  the evaluation for bacterial meningitis 
is polymerase chain reaction (PCR.) of the CSF. PCR has high sensitivity 
and specificity for the detection of bacteria such as S. pneumonia in the 
CSF, but  false-positive results have been reported. Other tests include 
real time PCR for rapid diagnosis of bacterial meningitis. Fluorescence In 
situ Hybridization (FISH). PCR is highly sensitive tool for rapid 
diagnosis of bacterial meningitis but it is costly. FISH  is useful for the 
identification of CSF samples which shows multiple bacteria during gram 
staining. 
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Management in ICU: 
• Fluid management 
• Antibiotic therapy 
• Anti oedema measures for cerebral oedema 
• Anti epileptics if patient is having seizures 
• Physiotherapy 
• Ventilator support if patient is in respiratory arrest 
ICU sepsis: 
Sepsis is more dangerous in patients in critical care. 
Severe sepsis is defined as one or more of the following 
1. Blood pressure < 90 mm of Hg or mean arterial blood pressure < 70 
mm of Hg that responds to administration of intra venous fluid. 
2. Urine output <0.5ml/kg/hr for 1 hour despite adequate fluid 
resuscitation. 
3. PaO2/FiO2 < 250 or if lung is the only dysfunctional organ 
PaO2/FiO2 <200  
4. Platelet cant < 80,000/ microlitre or 50 percent decrease in platelet 
over previous 3 days. 
5. Unexplained metabolic acidosis PH<7.3 or a base deficit > 5 meq/litre 
and a plasma lactate level of >1.5 times upper limit of normal 
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6. Pulmonary artery Wedge pressure > 12 mm of Hg or central venous 
pressure > 8 mm of Hg. 
Septic shock is systolic blood pressure <90mm of  Hg for at least 1 
hour despite adequate fluid resusitation or need for vasopressors to 
maintain systolic blood pressure > 90 mm of Hg or mean arterial pressure 
≥70 mm of Hg. 
Pathogenesis and complications: 
Pathogenesis: 
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Complications: 
1. Cardio pulmonary complications: 
- Can be due to ventilation- perfusion mismatch and increasing 
alveolar epithelial injury – Acute respiratory distress syndrome and 
sepsis induced hypotension due to decreased effective intravascular 
volume. 
2. Critical illness related corticosteroid insufficiency – manifesting as 
refractory hypotension. 
3. Renal failure:  
           Pre renal and acute renal failure due to acute tubular necrosis are 
common.  
4. Coagulopathy: 
 Thrombocytopenia and disseminated intravascular coagulation are 
common. 
5.  Neurologic complications: 
- Weaning from ventilator becomes difficult in the presence of 
critical care polyneuropathy. 
6. Immunosupression: 
– Patients with severe sepsis are profoundly Immuno suppressed (10) 
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Management : 
1) Hemodynamic resuscitation and acute life support 
2) Infection control 
3) Organ support and minimizing health care associated injury 
4)  Interventions to modify host inflammatory response  
These are the four important principles of sepsis management in 
ICU (11). 
Adult Respiratory Distress Syndrome: 
ARDS is the most common non infectious cause of lung infiltrates 
in ICU (12). This terminology was coined in the year 1967. It is 
otherwise called “shock lung”. Multi lobar pneumonia may be difficult to 
distinguish from an ARDS. 
Some of the commonest causes of ARDS are (13) 
1) Gram negative sepsis 
2) Pneumonia 
3) Near drowning 
4) Toxic fumes inhalation 
5) Multiple blood transfusions 
6) Aspiration of gastric contents 
7) Burns 
8) Pancreatitis 
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Pneumonia patients are at 10% risk of developing ARDS. In contrast 
50% of those with ARDS develop pneumonia during their ICU stay(14).  
Symptoms: 
Dyspnoea , tachypnoea and hypoxemia(15,16) 
Diagnostic criteria: 
BERLIN CRITERIA 2012 – EUROPEAN SOCIETY OF 
INTENSIVE CARE MEDICINE(17,18): 
1. Acute onset lung injury less than 1 week of an obvious clinical 
insult and with progression of respiratory symptoms 
2. Opacities on both lung fields not explained by other pulmonary 
pathology (e.g. pleural effusion, pneumothorax, or nodules) 
3. Respiratory failure not due to heart failure or volume overload 
4. Fall in arterial PaO2/FiO2 ratio: 
Mild :  201 - 300 mmHg (≤ 39.9 kPa) 
Moderate: 101 - 200 mmHg (≤ 26.6 kPa) 
Severe: ≤ 100 mmHg (≤ 13.3 kPa) 
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Principles of ARDS management in ICU: 
1) Low volume ventilation(19) 
2) Permissive hypercapnia(20) 
3) Promoting oxygen transport by improving cardiac output and 
haemoglobin levels by transfusion, if needed(21 - 23) 
4) Low PEEP (positive end expiratory pressure)(24) 
5) Steroids in the fibrinoproliferative phase(25) which promotes 
collagen breakdown and inhibits fibrosis(26) 
Multiorgan failure is the cause of death in majority of the ARDS 
cases. Less than 40% deaths are due to respiratory failure(27 - 31). This 
highlights the importance of integrated management in ARDS. So the 
management strategy in an ICU for ARDS should focus not on the lungs 
alone. 
Acute coronary syndromes: 
Cardiac illness takes away the major toll of human life. Coronary 
artery disease in 2004 represented 29% of global deaths killing 17.1 
million people worldwide according to WHO estimates.  
Acute myocardial infarction occurs when the coronary perfusion is 
not able to meet myocardial contractile demand (32). In an ICU setting 
MI is often underreported due to inability to communicate under 
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influence of sedation, analgesic drugs, trauma and sepsis. MI in ICU is 
associated with higher morbidity, mortality, complications and healthcare 
cost(33,34). 
In 2012, the Joint Task Force of the European Society of 
Cardiology, American College of Cardiology Foundation, the American 
Heart Association, and the World Health Federation 
(ESC/ACCF/AHA/WHF) redefined MI as a rise and/or fall of cardiac 
biomarkers with at least 1 value above the 99th percentile of the upper 
reference limit together with evidence of myocardial ischemia with at 
least 1 of the following (35). 
1. symptoms suggesting myocardial ischemia 
2. Q waves on electrocardiogram (pathological) 
3. New onset ST-T changes or left bundle branch block (LBBB) 
4. Acute loss of viable myocardium or a new regional wall motion 
abnormality 
5. Diagnosis of intracoronary thrombus by angiography or autopsy 
6. Sudden, unexpected cardiac death with symptoms suggestive of 
myocardial    ischemia and presumed new ST-segment elevation 
7. LBBB, and/or evidence of fresh thrombus by coronary 
angiography and/or autopsy. 
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So, Clinical signs and symptoms, electrocardiography, cardiac enzymes 
are vital in the diagnosis of acute MI(36). 
Management of acute MI in ICU(37 - 44): 
The scenario of acute MI management differs for critically ill and 
non critically ill patients. Comorbidties like renal failure, coagulopathies, 
sepsis, mechanical ventilation etc complicate the management. 
The principle treatment modalities are 
1) Oxygen, to maintain Sao2 > 90% 
2) Fibrinolysis, with streptokinase or r-tPA 
3) Nitrates for pain relief 
4) Morphine to relieve excruciating pain 
5) Anticoagulants and statins 
6) Antiarrhythmics  
7) Beta blockers 
8) Antiplatelets 
Percutaneous coronary intervention: 
In spite of all these non invasive strategies of management, early 
PCI offers a very favourable outcome in acute coronary syndrome, in an 
ICU patient (45 - 48). However coronary angiography is associated with 
adverse outcomes in critically ill patients(49). 
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Poisoning: 
All substances are poisons; there is none which is not a poison. The right 
dose differentiates a poison from a remedy.” 
                                               -    Paracelsus  
Poisoning cases utilise a significant amount of ICU resources. It is 
also one among the commonest cause of emergency ICU 
admissions(50,51). These patients also pose an immense diagnostic as 
well as therapeutic challenge because of the varied toxicology profile in 
each individual according to the agents they consumed. That depends on 
the socioeconomic status and the availability of agents at a particular 
point of time. The outcome of these patients  depend on dose of the agent 
consumed, comorbid illness, time from consumption to arrival at the 
treatment centre and quality of the health care provider(52 - 56). 
In India, the commonly consumed poison is agricultural 
pesticides(57), followed by alcohol intoxication, drug overdose. 
Incidence of poisoning is more among males and it has been noted in 
various studies across India (58,59). 
 
 
 
 8%
6%
Modes of poisoning: 
Majority of the poisoning occurs via ingestion of the substance. 
Most of them are suicidal and a few
depicted in the following pie chart
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6) Cardiorespiratory arrest 
7) Arrhythmias 
8) Multiorgan failure 
9) Rhabdomyolysis 
10)Metabolic acidosis or alkalosis  
Toxicology screening: 
Some of the commonly abused drugs detected by urine screening are(61) 
1) Amphetamines  
2) Barbiturates 
3) Benzodiazepines 
4) Cannabinoids 
5) Cocaine 
6) Phencyclidine 
7) Opioids. 
Treatment: 
Patients should be assessed for their level of consciousness. Any head 
injuries or spinal cord injuries should be ruled out. Some of the 
management strategies used in ICU are 
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• Coma cocktail, comprising of thiamine, dextrose and naloxone can 
be given. It can be both diagnostic and therapeutic(62). 
• Flumazenil can be given if benzodiazepine overdose is suspected 
(63) 
• Apart from this, removal of toxin exposure can be done by skin 
decontamination, ocular and gastric decontamination. 
• Toxins absorbed through GI tract can be cleared by 
1) Emesis 
2) Gastric lavage 
3) Whole bowel irrigation 
4) Activated charcoal with cathartic 
• Urinary alkalization for compounds like salicylic acid, 
Phenobarbital, methotrexate, isoniazid etc.  
• Hemoperfusion 
• Hemodialysis for renal failure due to nephrotoxic compounds 
• Antidotes can be used for specific poisons. One of the importance 
of identifying the compound taken is for the purpose of 
administering antidote. Some of the commonly used antidotes in 
ICU are 
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Acetaminophen  N acetyl cysteine 
Anticholinergic Physostigmine  
Anticholinesterase  Atropine  
Cyanide Amyl nitrite, sodium nitrite 
Digoxin Digoxin specific antibody 
Methanol Ethanol/ fomepizole 
Opioids Naloxone  
Organophosphate Atropine  
  
Corrosive substances: 
Corrosive agents are present in many house hold things we use 
daily. It is available in various forms and it is one among the commonest 
substances ingested or got exposed  to either intentionally as in case of 
suicide attempt, accidentally as in a workplace. 
Most of the agents contain either acid or an alkali. The 
pathophysiology of injury caused by both acid and alkali are different.  
Alkali: 
The mechanism of damage due to ingestion of alkali is by 
formation of hydroxyl ions due to contact of alkali with the tissue. It 
causes liquefaction necrosis. Collagen destruction, fat saponification, 
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emulsification of cell membrane, transmural thrombosis and cell death. 
All these leads to vascular thrombosis in the area of contact. 
Acid: 
Acid injury causes coagulation necrosis. Contact of acid with tissue 
surface causes cellular protein dessication, denaturation and precipitation. 
Alkali ingestion causes severe damage to oesophagus followed by 
stomach due to increased tissue binding of alkalis and acid ingestion 
causes more injury to stomach, sparing the oesophagus most of the times, 
due to rapid transit of acid down the oesophagus. 
Concerns in ICU: 
Corrosive ingestion, when the manifestations are severe it can 
cause metabolic acidosis, disseminated intravascular coagulation and 
which in turn can lead to a multiorgan dysfunction. 
Management: 
First hand management comprises of securing the airway which 
may be injured or stenosed due to the corrosive substance. Airway should 
be secured using a an endotracheal tube using fibreoptic endoscopy, to 
avoid injury to edematous tissue causing  perforation, by the method of 
blindly poking an endotracheal tube as which is used routinely.  
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An ET tube of smaller size at least 1 – 2 cm than which is routinely 
used, should be used to secure the airway in the presence of laryngeal 
edema. 
  Parenteral steroids relieve airway edema to some extent. 
At times patient may need emergency procedures like 
tracheostomy in the presence of severe airway edema, in which the 
insertion of an endotracheal tube may be difficult. 
Milder forms of injury settles with medical management. While severe 
forms of injury may need surgical intervention. 
Snake bite: 
Most of the Indian population lives in rural areas where agriculture 
is the predominant occupation. Snake bite is a common health hazard in 
these areas. In 1953 Porge pointed out that over 25,000 human lives were 
taken away every year due to poisonous snake bite in the Indian 
subcontinent (64) 
Government of India data, cited by WHO , 2010 stated that 50,000 
deaths have been reported each year(65). 
Nearly 216 species of snakes are identified in India, of which 52 
species are poisonous.  
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Medically important species of snakes are cobra, common krait, 
russell’s viper and phursa.  
Among these elapidae and viperidae are of highest medical 
importance and are classified as category I, which results in high levels of 
morbidity, disability and mortality. 
Snake venom: 
Ophitoxaemia is the term used to describe the clinical spectrum of 
snake bite envenomation. 
Snake venom is a modified saliva is produced by special glands of 
snakes. Zootoxin is secreted by glands which are a modification of the 
parotid salivary gland and are situated below and behind the eye on either 
side, encapsulated in the muscular sheath. 
Large alveoli in the glands store the venom before being conveyed 
by the duct to the tubular fangs through which it is injected.  
It is injected either subcutaneously or intramuscularly. 
Chemistry: 
Snake venom is a composition of protein, enzymes, cytotoxic 
substances, neurotoxins, coagulants and anticoagulants. 
It has acidic Ph. 
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Specific gravity is 1.03 and is water soluble. 
Digestion of proteins is caused by oxidases and proteases 
Phosphodiesterase A2 causes hemolysis by lysing RBC membranes 
Neurotoxins: 
1) Fasciculins 
2) Dendrotoxins 
3) Alpha neurotoxins 
Cytotoxins: 
1) Phospholipases 
2) Cardiotoxins 
3) Haemotoxins 
Signs of envenomation: 
Systemic manifestations: 
Most often the patients complain of  
• Abdominal pain 
• Nausea 
• Vomiting 
• Weakness 
• Hyperaesthesia of abdominal skin 
  
37 
 
• Weakness 
• Drowsiness  
• Ptosis 
• Respiratory and bulbar paralysis 
• Cardiogenic and vasogenic shock 
• Myoglobinuria and renal tubular acidosis with bite of sea snakes 
Local manifestations: 
• Fang marks can be seen in the bite site 
• Cellulitis 
• Abscess formation and necrosis 
• Pain 
• Serosanguinous discharge 
• Myalgia 
• Regional lymphadenopathy 
• Gangrene formation may lead to limb loss 
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Properties of snake venom according to species and lethal dose: 
Species Venom ejected per 
bite 
Lethal dose 
Cobra 200 mg 15 mg 
Russell’s viper 150 mg 40 mg 
Krait 22 mg 1 mg 
Echis  4.6 mg 4 mg 
 
Management of snake bite in ICU: 
Aggressive management strategies should be adopted in managing 
cases. When intervened promptly morbidity and even mortality could be 
avoided.  
A quick and detailed history is important along with physical 
examination with special attention to the bitten limb. 
General examination, cardiovascular, pulmonary and neurological 
examinations should be done to assess systemic involvement and 
associated complications. 
  
  
39 
 
Investigations: 
• Complete blood counts 
• Renal function test 
• Urine routine examination 
• Coagulation profile 
• ABG analysis 
• Liver function test 
• Creatine phosphokinase  
• Saturation monitoring 
Treatment strategies: 
• Tetanus toxoid should be administered to all patients 
• Broad spectrum antibiotics should be administered to prevent 
spread of infection 
• Anti snake venom 
• Mechanical ventilation if patient is having respiratory distress 
• Fasciotomy and limb support if compartment syndrome is present 
• Blood transfusion, platelet and fresh frozen plasma transfusion as 
and when needed to manage complications like bleeding due to 
DIC or septicaemia 
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Anti snake venom: 
The anti snake venom (ASV) used in India is polyvalent. It is 
effective against russells viper, common cobra, common krait and saw 
scaled viper. Monovalent ASV is not used in India.  
Criteria for ASV administration: 
ASV is costly and anaphylactic reactions may occur following 
administration. Therefore unnecessary usage should be avoided. 
ASV should be administered only if any of the following 
manifestations occur 
• Evidence of coagulopathy – WBCT >20 minutes. 
• Evidence of neurotoxicity – ptosis, muscle paralysis, external 
ophthalmoplegia. 
• Persistent severe vomiting or abdominal pain. 
• Rapid extension of cellulitis. 
• Swelling of more than half of the bitten limb. 
Neuromyopathies in critically ill: 
Sir William osler first described muscle weakness and atrophy 
occurring during critical illness and sepsis (66). The prevalence varies in 
ICU from 20 – 90 %.  
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Cytokines and free radicals released as a result of SIRS, affects the 
microcirculation of the central and peripheral nervous system(67). 
Critical illness polyneuropathy occurs as a rare complication of sepsis and 
multiorgan failure.  
Pathogenesis: 
The disturbed humoral and cellular response in SIRS and MODS 
results in increased capillary permeability and endothelial damage. This 
results in microcirculatory dysfunction with tissue hypoxia (68). Certain 
patients need corticosteroids and neuromuscular blocking agents which 
also adds to the oxidative stress. 
Both total and reduced form of glutathione is decreased in muscle. 
This results in mitochondrial injury and oxidative stress.  
The weakness can be due to neuropathy, myopathy or 
polyneuropathy. The term critical care illness weakness (CIW) 
encompasses all these entities. 
Spectrum of CIW: 
1) Myopathic component 
2) Neuropathic component 
3) Neuromuscular junction component 
4) Metabolic component 
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5) Encephalopathic component 
Critical illness neuropathy(CIN): 
This entity was first described by Charles Bolton in 1984(69). It 
occurs in 50 – 70% of those who develop SIRS.  Since SIRS is more 
common in ICU setting, CIN gains importance as an important cause of 
acute polyneuropathy. It is a distal axonopathy of both motor and sensory 
axons. It presents with flaccid weakness and loss of tendon reflexes. 
Nerve conduction studies will show involvement of phrenic nerves 
(70). This results in difficulty in weaning from mechanical ventilator. 
This prolongs the ICU stay and increases the morbidity. Other 
causes like Guillain – Barre Syndrome (GBS), Botulism, myasthenic 
crisis and porphyria are also causes for acute weakness in ICU.    
Diagnostic criteria for CIN: 
1) The patient is critically ill 
2) Limb weakness or difficulty in weaning patient from ventilator 
after non neuromuscular causes such as heart and lung diseases 
have been excluded 
3) Electrophysiological evidence of axonal motor and sensory 
polyneuropathy. 
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4) Absence of decremental response on repetitive nerve stimulation. 
Other acute axonal polyneuropathies such as porphyria, thiamine 
deficiency etc should be excluded. 
Definite diagnosis of CIP – if criteria 1 – 4 is fulfilled. 
Probable diagnosis of CIP – if criteria 1,3 and 4 are fulfilled. 
Diagnosis in ICU – acquired weakness is established if only criteria 1 
and 2 are fulfilled 
Critical illness myopathy(CIM): 
This is an acute myopathy of critically ill patients. CIM occurs in at 
least one third of patients treated for status asthmaticus. 
Electrophysiological and muscle biopsy evidence of primary myopathy is 
seen in all of the 22 critically ill patients involved in one prospective 
study. The clinical features overlap with critical illness polyneuropathy 
and neuromuscular junction blockade. It involves neck flexors, limbs, 
diaphragm and facial muscles. This causes difficulty in weaning from 
ventilator. 
 Some of the forms of myopathy are 
1) Acute quadriplegic myopathy 
2) Acute necrotising myopathy of intensive care 
3) Thick filament myopathy 
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4) Acute corticosteroid myopathy 
5) Acute hydrocortisone myopathy 
6) Acute myopathy in severe asthma 
7) Acute cortoicosteroid and pancuronium associated myopathy and 
8) Critical care myopathy 
Diagnostic criteria for critical illness myopathy: 
Major: 
1) Sensory nerve action potential amplitudes more than 80 % of the 
lower limit of  normal(LLN) in two or more nerves 
2) Needle EMG, with short duration, low amplitude motor unit 
potentials(MUPs) with early or normal full recruitment, with or 
without fibrillation potentials. 
3) Absence of decremental response on repetitive nerve stimulation. 
4) Muscle histopathologic findings of myopathy with myosin loss. 
Minor: 
1) Compound muscle action  potentials(CMAP) less than 80 % LLN 
in two or more nerves without conduction block. 
2) Elevated serum creatine kinase. 
3) Demonstration of muscle excitability. 
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As per definition, patient should have developed weakness after the 
onset of critical illness. 
Definitive diagnosis – patients should have all four major criteria 
Probable diagnosis – patients should fulfil three major criteria and one 
or more minor criteria 
Possible diagnosis – major criteria 1 and 3 or 2 and 3, and one or more 
minor criteria 
Nerve conduction study in CIM will show (71) 
 Low amplitude 
 Broadened or absent CMAPs 
 Relatively preserved SNAPs 
Predictors of outcome: 
Limb and diaphragmatic weakness can persist for weeks and 
months after an episode of CIW. 
In a study conducted by Leitjen in 50 patients undergoing 
mechanical ventilation, he found that 29 patients developed peripheral 
neuropathy. Those patients also had the highest ICU mortality. 
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De Jonghe et al have also found that the requirement of prolonged 
weaning period can be predicted by the incidence of ICU acquired 
paresis.  
It is also important to identify CIW, since it prolongs the stay of 
the patient in ICU. This is especially important in a resource limited 
setting to cut down the cost and manage them efficiently. 
How to prevent CIW: 
1) Early rehabilitation 
2) Early passive mobilisation 
3) Electrical muscle stimulation 
4) Daily cycle sessions with bedside ergometer 
These measures have been found to improve the power of quadriceps 
muscle. 
Patient assessment in ICU: 
An ICU is the place where critically ill patients are managed and 
require continuous monitoring. It takes a lot of resources in the form of 
cost, manpower and costly equipments. With overflow of cases we need 
to know which group of patients in an ICU needs utmost priority for 
utilisation of these costly resources. The priority may also change 
according to the improvement or deterioration of patients on an everyday 
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basis. So to assess who needs considerable amount of care at one 
particular point of time we need certain guidelines based on evidence. 
Here comes the role of scoring systems. These systems were designed 
based on simple clinical parameters which can be done on the  bed side 
and basic laboratory parameters which are available in most of the 
centres.  
Scoring systems: 
A few of the most commonly used such systems are  
 1) APACHE  
 2) SOFA  
 3) Simplified acute physiology score (SAPS) 
 4) Mortality probability model (MPM) 
 5) Therapeutic intervention scoring system (TISS) 
 6) Logistic organ dysfunction score (LODS) 
           7) Multiorgan dysfunction score (MODS) 
Among these SOFA, MODS and LODS are organ dysfunction 
scoring system. APACHE, SAPS II and MPM II are general severity 
scoring systems. 
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APACHE SCORING SYSTEM: 
  Knaus et al developed APACHE scoring system in 1985(72). It 
consists of 12 physiological variables calculated by multivariate analysis. 
The scores ranges from 0 – 71. The data of APACHE II are calculated 
using the equation 
IN HOSPITAL MORTALITY  
 (R/1-R) = -3.517 + (APACHE Ⅱ × 0.146 + S + D) 
 R = Risk of death in hospital, S = Risk due to emergency surgery, and D 
= Risk due to any specific disease.  
A score of 25 or less denotes less than 50% mortality and score of 
35 or more denotes more than 85% mortality. Although APACHE II 
score provides severity of illness of particular group of patients, they 
provide little information about the risk of individual patients(73). As an 
improvised version of APACHE II, APACHE III and IV were designed 
for better prediction. 
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Simplified acute physiology score(SAPS): 
Simplified acute physiology score was introduced by Le Gall et al 
in 1984(74). It was designed to encounter the difficulties faced during 
assessment of APS used in APACHE score. It was calculated by taking 
the 13 most easily measurable physiological variables used in APACHE 
score. The total score is obtained as the highest score of ICU admission in 
the first 24 hours. SAPS had its advantage over APACHE II in accurately 
predicting mortality in a stratified group of patients. 
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Mortality probability model: 
Lemeshow et al in 1985, first published the mortality prediction 
model(75). He designed 4 models, like probability of death from data 
collected at ICU admission(MPM0), Probability of death based on 24 
hours data(MPM24)probability of death based on 48 hours data(MPM48), 
probability of death over a period of time based on MPM0 and change in 
probability between MPM0 and MPM24 and change in probability between 
MPM24 and MPM48. Lemeshow et al also developed MPM II to assess 
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serial changes in ICU patients over 72 hours of ICU stay. Hence this 
model had a better advantage over APACHE and SAPS since these two 
models lack ability of serial assessment.  
 
 
THERAPEUTIC INTERVENTION SCORING SYSTEM: 
 Cullen et  al in 1974 developed this scoring system(76). It utilises 76 
monitoring and therapeutic parameters. Scores of the first three day ICU 
stay correlate well with survival. So it is useful in discriminating 
survivors and non survivors, according to whether the score increases or 
decreases, respectively. 
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LOGISTIC ORGAN DYSFUNCTION SCORE: 
Logistic organ dysfunction score was developed in 1996, using 
datas collected from various ICU(77). A score was made with the 
evaluation of 6 organ systems and 12 variables were analysed. The 
grading is between 0 and 5 for each organ. The worst value of score 
obtained  in the first 24 hours of icu stay is documented. Though it is not 
much useful in serial assessment of patients it can assess improvement or 
worsening of organ dysfunction. 
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All these existing severity scoring systems utilise a large number of 
variables and involves a large number of blood investigations which may 
not be available in all centres except for a sophisticated ICU set up. In an 
emergency it is difficult to do all such investigations and do a detailed 
assessment. Also it is so costly to follow up patients with all such 
investigations. This warranted the need for a simplified scoring system 
for easy evaluation of patients. 
SOFA SCORING SYSTEM: 
The SOFA score  was developed in 1994, by the European Society 
of Intensive Care and Emergency Medicine, to provide a means to 
describe the degree of organ failure in individuals and groups of ICU 
patients. Vincent et al published the SOFA score and proved that infected 
patients had more risk of organ dysfunction than the non infected (78) 
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SOFA scoring system analyses 6 variables namely  
1) Pao2/Fio2 ratio(for respiration) 
2) Platelets(for coagulation) 
3) Bilirubin (for liver function) 
4) Creatinine (for renal function) 
5) Glasgow coma scale(to assess level of consciousness) 
6) Blood pressure and the need for inotropic support.  
A score of 0 to 4 is given for each of these six variables and a score is 
obtained using sum total value of each of these parameters. The worst 
values on each day are recorded and organ function total score can thus 
be monitored over time (79) 
The increasing SOFA score and the mean SOFA score are highly 
useful in assessing prognosis and risk stratification of patients (80 - 82). 
Parameters: 
Pao2/Fio2 ratio: 
It is simply defined as the amount of  inspired oxygen that reaches 
the blood. It is impaired in case of lung injury due to any cause. It is also 
called carrico index. A Pao2/Fio2 ratio of less than or equal to 200 is 
required for the diagnosis of acute respiratory distress syndrome 
according to the AECC criteria(83). 
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Pao2 is the partial pressure of oxygen in the arterial blood. It is 
measured in millimetres of mercury(mmHg) or torr units. It is measured 
by an arterial blood gas analyser(ABG). Normal Pao2 is 75 – 100mmHg. 
Fio2 is the percentage of oxygen in the inspired mixture of air. 
Normal Fio2 in inspired atmospheric air is 0.21(21%). In a mechanical 
ventilator it is usually set as 30 – 40%. In a mechanically ventilated 
patient 100% oxygen is not administered due to high risk of oxygen 
toxicity. 
Kerbing and his co workers assessed the clinical relevance of 
variation in Pao2/Fio2 ratio(84). They demonstrated the clinical utility of 
this parameter. 
The Pao2/Fio2  scores are 
Score 0 – more than  400 
Score 1 – less than or equal to 400 
Score 2 – less than or equal to 300 
Score 3 – less than or equal to 200 
Score 4 – less than or equal to 100. 
  Creatinine: 
In SOFA scoring serum creatinine values are estimated periodically to 
assess the renal function over a period of time till the patient is in icu. 
Creatinine is a breakdown product of creatin
in muscle. Each day 1
It  is excreted both by glomerular filtration an
serum creatinine is a marker of damage to nephrons. Normal serum 
values are 0.7 – 1.2(males) and 
function can be due to pre renal, renal or post renal causes. Some of the 
commonest causes of 
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d tubular secretion. Rise in 
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renal failure are 
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1) Severe dehydration 
2) Acute pyelonephritis 
3) Diabetes  
4) Hypertension 
5) Renal calculi 
6) Hemorrhagic fevers 
7) Disseminated intravascular coagulation 
8) Autoimmune and other connective tissue disorders. 
The scores used for creatinine in SOFA score are, 
Score 0 – less than 1.2 mg/dl 
Score 1 – 1.2 to 1.9 mg/dl 
Score 3 – 2.0 to 3.4 mg/dl 
Score 4 – 3.5 to 4.9 mg/dl 
Score 5 – more than 5 mg/dl 
Platelet count: 
Platelet count is used as a parameter in SOFA score to assess 
coagulation function and its impairment during disease states. The 
coagulation mechanism involves activation, adhesion and aggregation of 
platelets in response to a stimuli, say an injury or infection. Both platelet 
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number and function should be adequate for this function to be intact. 
Coagulation cascade is one of the best understood system in humans (85). 
Primary hemostasis is mainly due to platelets, which is characterised by 
formation of platelet plugs (86). Activated platelets release stored 
granules into the blood. These granules contain 
1) Serotonin 
2) ADP 
3) Platelet activating factor 
4) Platelet factor 4 
5) Vonwillebrand factor 
6) Thromboxane A2 
All these substances when released into the blood stream activate 
additional platelets. These steps lead on to the activation of various 
enzymes of coagulation cascade resulting in activation of clotting factors, 
which is called secondary hemostasis. 
Various systemic illness can be associated with a decreased platelet 
count. 
It can be either due to decreased production, increased destruction or 
impairment of platelet function.   
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Causes of  thrombocytopenia: 
1) Vitamin B12 and folate deficiencies 
2) Infections like HIV disease 
3) Leukemias 
4) Disseminated intravascular coagulation 
5) Thrombotic thrombocytopenic purpura 
6) Viral infections 
7) Gram negative septicaemia 
8) Heparin induced thrombocytopenia 
9) Radiation induced bone marrow suppression 
10) Drug toxicity 
The scores used for platelet count in SOFA are 
Score 0 - >150 × 10
3
/mm
3
 
Score 1 - <150× 10
3
/mm
3
 
Score 2 - <100× 10
3
/mm
3
 
Score 3 - <50× 10
3
/mm
3
 
Score 4 - <20× 10
3
/mm
3
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Bilirubin: 
Bilirubin levels are measured as a marker of liver function. Liver 
plays a pivotal role in regulating a large number of metabolic pathways in 
the body. Bile is secreted in the hepatic lobules and it drains ultimately 
into the bile duct after traversing through canaliculi, small bile ducts and 
larger bile ducts (87). 
It consists of bile acids, phospholipids and unesterified cholesterol. 
Daily bile output from the liver is 500 – 600ml. It consists of two 
fractions. Direct or hydrophilic type and indirect or hydrophobic type. 
Conjugation of indirect to direct fraction takes place in the liver, which is 
an enzyme mediated process. This whole array of steps in the formation 
to elimination of bile can be disturbed in disease states. Elevations in 
bilirubin levels can be used to assess liver function over time, which 
helps in predicting worsening or improvement of liver function in an ICU 
patient. 
Some of the conditions in which bilirubin levels are raised are, 
1) Acute hepatitis 
2) Alcoholic liver disease 
3) DIC and septicaemia 
4) Hepatocellular carcinoma 
5) Autoimmune and connective tissue disorders 
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6) Storage disorders 
7) Haemolytic jaundice 
8) Obstructive jaundice 
9) Congenital liver enzyme abnormalities 
10) Massive blood transfusion  
Most biologic system in the body gets affected by excess bilirubin in 
blood. Normal bilirubin levels in blood are 1.0 to 1.5mg/dl (88). Upto 
30% of that is direct or conjugated bilirubin, which equals 0.3 mg/dl. It is 
water soluble. The rest of the fraction is insoluble in water and it is called 
unconjugated bilirubin.  
This is the toxic form of bilirubin, which when accumulates in 
excess gets deposited in the brain especially in the basal ganglia which 
may lead to seizures or neurological deficits.  
The scores used for bilirubin are 
Score 0 - < 1.2 mg/dl 
Score 1 – 1.2 to 1.9 mg/dl 
Score 2 – 2.0 to 5.9 mg/dl 
Score 3 – 6.0 to 11.9 mg/dl 
Score  4 - >12 mg/dl 
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Glasgow coma scale: 
It gives a reliable and objective way of  recording the conscious 
state of a person. It is easy to use both for the medical and paramedical 
personnel for initial as well as continuing medical assessment in an ICU. 
It has value in predicting ultimate outcome. Three types of responses are 
assessed. 
GCS scale was used initially only for head injury patients. Now it 
is being used both for acute medical and trauma patients. It is also being 
used to monitor patients in ICU in a seriously ill state (89). The scale was 
published in 1974 by Graham Teasdale and Bryan J. Jennett, at 
the University of Glasgow Institute of Neurological Sciences. Both of 
them were neurosurgeons. 
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The highest possible score is 15, that is in a fully awake person. The 
lowest possible score is 3, which means deep coma or death.  
The scores used for GCS in SOFA are 
Score 0 – 15 
Score 1 – 13 to 14 
Score 2 – 10 to 12 
Score 3 – 6 to 9 
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Score 4 - <6 
Blood pressure: 
“There is no doubt that proper functioning of our pipes and pumps does 
have an immediate urgency well beyond that of  almost any of our other 
bits and pieces”.  
- Steven vogel (vital circuits,1992) 
Hypotension and shock may occur as a final consequence of any 
organ dysfunction. Maintaining an adequate blood pressure is essential 
for perfusion and oxygenation of vital organs. In short, shock is a clinical 
syndrome resulting from inadequate tissue perfusion of any cause, 
resulting in an imbalance between the requirement and supply of oxygen, 
causing cellular dysfunction. This goes on and on like a vicious cycle 
resulting in cellular death and multi organ dysfunction. 
In an ICU setting cardio respiratory complications are the most 
common cause of  circulatory collapse and shock  
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Classification of shock: 
Hypovolemic Septic 
Traumatic Hyperdynamic(early) 
Cardiogenic Hypodynamic(late) 
Intrinsic Neurogenic  
Compressive Hypoadrenal  
 
 
 
 
 
                      SHOCK INDUCED VICIOUS CYCLE 
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The scores used for blood pressure in SOFA are 
Score 0 – No hypotension 
Score 1- Mean arterial pressure <70 
Score 2 – dopamine infusion </= 5 or requiring dobutamine 
Score 3 – dopamine infusion >/= 5 or requiring nor epinephrine </=0.1 
Score 4 – dopamine infusion > 15 or or requiring nor epinephrine 0.1 
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MATERIALS AND METHODS 
Study design: 
Prospective observational cohort study 
Study group: 
Patients admitted to the intensive medical care unit of Coimbatore 
medical college hospital 
Study duration: 
One year (May 2013 – May 2014) 
Inclusion criteria: 
• Age > 15 years 
• Patients admitted to the intensive care unit with suspected 
sepsis/multiorgan dysfunction 
Exclusion criteria: 
• Age < 15 years 
• Patients with less than 48 hours of ICU stay 
• Patients who are extremely moribund, who may not survive for 
more than 48 hours 
• Pregnant patients 
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Sample size: 
A total of 100 patients admitted to Coimbatore medical college 
ICU were studied 
Consent: 
Informed consent will be taken as per the standard procedures in 
the institution 
Ethical clearance: 
 Obtained from the ethical committee of the institution  
Procedure: 
Critically ill suspected multi organ dysfunction patients admitted 
will be chosen for study if they fulfil the inclusion criteria and parameters 
needed to calculate SOFA score will be obtained from a patient on 
admission, 48 and 96 hours after admission at the same time of the day. 
The scores will be calculated till day 6 or till mortality occurs whichever 
is earliest. 
Blood Investigations will be taken under aseptic conditions with 
adequate care and sent to the hospital 24 hours laboratory immediately. 
All the investigations are done in our hospital and no investigations or 
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procedure will be done outside the hospital. Any experimental or so far 
unused materials or methods will not be used on the patients. 
Serum bilirubin will be calculated using an auto analyser using the 
method of malloy and evelyn. 
ABG was done using ion selective electrode in an ABG analyser 
Platelet count was done using sysmex KX21.3 which is an 
automated cell count analyser, in clinical pathology lab. 
Statistical analysis: 
Data will be analysed using SPSS software version 17.  
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RESULTS 
Survivors and non survivors: 
Among the 100 patients involved in the study 53% survived and 
47% succumbed to their illness. The minimum age of the person enrolled 
in the study was 17 and the maximum age was 85. 
 
SOFA score on admission: 
SOFA score Survivors Non survivors Total 
6 – 7 5 1 6 
8 – 9 19 7 26 
10 – 11 13 4 17 
12 and above 16 35 51 
Total 53 47 100 
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The minimum SOFA score of the patients admitted was 6. Hence 
the data column starts with values of 6 and above. This table shows that 
there is a sharp rise in non survivors at a SOFA score above 12. 
                          
ROC curve for admission SOFA 
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Area Under the Curve 
Test Result Variable(s): SOFAADMISSION 
Area Std. Error
a
 
Asymptotic 
Sig.
b
 
Asymptotic 95% 
Confidence Interval 
Lower 
Bound 
Upper 
Bound 
.760 .048 .000 .665 .855 
 
The test result variable(s): SOFAADMISSION has at least one tie 
between the positive actual state group and the negative actual state 
group. Statistics may be biased. 
a. Under the nonparametric assumption 
b. Null hypothesis: true area = 0.5 
Bar chart: 
No. of deaths 
 
                                SOFA score 
1
7
4
35
0
10
20
30
40
SOFA 6 - 7 SOFA 8 -9 SOFA 10 - 11 SOFA 12 and 
above
Admission SOFA
Series 1
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The minimum admission SOFA score of patients in this study is 6. 
Among the 6 patients who had this score 1 patient expired. That is, the 
mortality rate is 16.7 %. Among the 61 patients who had an admission 
SOFA score of 12 and above 35 patients expired escalating the mortality 
rate to 68.6 %. 
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SOFA at 48 hours for non survivors: 
 
 
SOFA score 
 
No. of Non survivors 
8 – 9 3 
10 - 11 4 
12 and above 40 
 
At 48 hours the minimum SOFA score observed among the study 
population is 8. Hence the data column starts with 8 and above. 
Area Under the Curve 
Test Result Variable(s):SOFA48Hr 
 
Asymptotic 95% Confidence 
Interval 
Area 
Std. 
Error
a
 
Asymptotic 
Sig.
b
 Lower Bound Upper Bound 
.914 .028 .000 .859 .970 
 
The test result variable(s): SOFA48Hr has at least one tie between 
the positive actual state group and the negative actual state group. 
Statistics may be biased. 
a. Under the nonparametric assumption 
b. Null hypothesis: true area = 0.5 
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3 4
40
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SOFA at 48 hours
Series 1
 ROC curve for SOFA at 48 hours: 
 
 
 
 
 
 
 
 
 
 
 
 
No. Of deaths 
                                                 SOFA score 
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This picture shows that a SOFA score of 12 and above at 48 hours 
of admission shows an increase in the number of non survivors. The 
minimum SOFA score of the study population at 48 hours is 8. Among 
the 47 non survivors, 3 patients had these minimum score. Patients who 
had a score of 12 and above were 40. 
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SOFA score at 96 hours for non survivors : 
 
SOFA score No. Of non survivors  
8 – 9 3 
10 – 11 3 
12 and above 41 
 
 
ROC curve at 96 hours: 
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3 3
41
0
5
10
15
20
25
30
35
40
45
SOFA 8 - 9 SOFA 10 - 11 SOFA 12 and above
SOFA score at 96 hours
Series 1
Area Under the Curve 
Test Result 
Variable(s):SOFA96HR 
Asymptotic 95% Confidence 
Interval 
Area 
Std. 
Error
a
 
Asymptotic 
Sig.
b
 Lower Bound Upper Bound 
.937 .023 .000 .892 .982 
 
Bar diagram: 
No. Of deaths 
 
 
 
 
 
 
 
 
 
     SOFA score 
This chart depicts that survival rate is reduced when the SOFA 
score increases above 12, at 96 hours of admission. At 96 hours 41 out of 
the 47 patients expired, had a score of 12 and above. 
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Delta SOFA: 
It is the difference between the subsequent SOFA scores. ∆ SOFA 
48 is the difference between admission score and the score at 48 hours. 
∆SOFA 96 is the difference between the score at 48 hours and 96 hours. 
SOFA score 48 hour changes: 
The patient data is analysed as those who decreased, unchanged 
and increased from the initial score respectively, and the outcome is 
analysed. 
 
 
 
 
 
  
∆ SOFA 48 Survivors Non survivors 
Decreased  35 6 
Unchanged 8 9 
Increased  10 32 
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Area Under the Curve 
Test Result Variable(s):SOFA48 
difference 
Asymptotic 95% Confidence 
Interval 
Area Std. Error
a
 
Asymptotic 
Sig.
b
 Lower Bound Upper Bound 
.830 .041 .000 .749 .910 
 
SOFA 48 hour changes: 
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No. Of deaths 
 
                                                   SOFA score 
These data depicts that when the SOFA score is increased from 
admission to 48 hours, there is an increase in mortality. On contrary the 
mortality rate has decreased when the score falls. Among the 47 non 
survivors 32 (68.08%) had an increase in their ∆48 scores. 
 
 
  
6
9
32
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5
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SOFA score 96 hour changes: 
The patient data is analysed as those who decreased, unchanged 
and increased from the initial score respectively, and the outcome is 
analysed. 
∆ SOFA 96 Survivors Non survivors 
Decreased 39 7 
Unchanged 7 2 
Increased 7 38 
 
SOFA 96 hour changes: 
Figure 6: 
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Bar chart: 
No. Of deaths 
 
                                          SOFA score 
This chart depicts mortality rate is increased when the SOFA score 
is increased from admission to 96 hours. On contrary, the mortality 
rate has decreased when the score falls. Among the 47 non survivors 
38 (80.85%) had an increase in their ∆  96 scores. 
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Mean SOFA: 
Mean SOFA calculates the average value of the prognostic score during 
the entire ICU stay of the patient. 
 
Test Result 
Variable(s):MEANSOFA 
 
  
Area Std. Error
a
 
Asymptotic 
Sig.
b
 
Asymptotic 95% 
Confidence Interval 
Lower 
Bound Upper Bound 
.908 .029 .000 .851 .966 
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Coordinates of the Curve 
Test Result Variable(s): MEANSOFA 
Positive if Greater Than or Equal Toa Sensitivity 1 – Specificity 
4.3333 1.000 1.000 
5.6667 1.000 .962 
6.3333 1.000 .925 
7.0000 1.000 .755 
7.5000 1.000 .660 
7.8333 .979 .642 
8.1667 .957 .623 
8.5000 .936 .623 
8.8333 .936 .491 
9.1667 .936 .472 
9.5000 .915 .434 
10.0000 .915 .396 
10.5000 .894 .321 
10.8333 .872 .226 
11.167 0.87 0.17 
11.5000 .830 .151 
11.8333 .809 .132 
12.1667 .766 .132 
12.5000 .723 .113 
12.8333 .660 .075 
13.1667 .660 .057 
13.5000 .617 .000 
13.8333 .574 .000 
14.1667 .532 .000 
14.5000 .489 .000 
14.8333 .404 .000 
15.1667 .383 .000 
15.5000 .319 .000 
16.1667 .277 .000 
16.8333 .213 .000 
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17.1667 .191 .000 
17.5000 .149 .000 
18.0000 .106 .000 
18.5000 .064 .000 
20.0000 .021 .000 
22.3333 .000 .000 
 
The test result variable(s): MEANSOFA has at least one tie 
between the positive actual state group and the negative actual state 
group. 
a. The smallest cutoff value is the minimum observed test value 
minus 1, and the largest cutoff value is the maximum observed test value 
plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
These data shows that, a mean SOFA score of 11 and above is an 
excellent predictor of mortality, above which the number of non survivors 
increase. 
Total SOFA: 
It is the sum total of all the scores obtained from an individual 
patient during his hospital stay. It gives information about the severity of 
the illness since gives the total worst score of all organs.  
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Area under the curve: 
Test Result 
Variable(s):TOTALSOFA 
Table 11: 
Asymptotic 95% Confidence 
Interval 
Area 
Std. 
Error
a
 
Asymptotic 
Sig.
b
 Lower Bound Upper Bound 
.908 .029 .000 .851 .966 
 
Coordinates of the Curve 
Test Result Variable(s): TOTALSOFA 
Positive if Greater 
Than or Equal To
a
 Sensitivity 1 – Specificity 
15.0000 1.000 1.000 
17.0000 1.000 .962 
19.0000 1.000 .925 
21.0000 1.000 .755 
22.5000 1.000 .660 
23.5000 .979 .642 
24.5000 .957 .623 
25.5000 .936 .623 
26.5000 .936 .491 
27.5000 .936 .472 
28.5000 .915 .434 
30.0000 .915 .396 
31.5000 .894 .321 
32.5000 .872 .226 
33.500 0.87 0.17 
34.5000 .830 .151 
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35.5000 .809 .132 
36.5000 .766 .132 
37.5000 .723 .113 
38.5000 .660 .075 
39.5000 .660 .057 
40.5000 .617 .000 
41.5000 .574 .000 
42.5000 .532 .000 
43.5000 .489 .000 
44.5000 .404 .000 
45.5000 .383 .000 
46.5000 .319 .000 
48.5000 .277 .000 
50.5000 .213 .000 
51.5000 .191 .000 
52.5000 .149 .000 
54.0000 .106 .000 
55.5000 .064 .000 
60.0000 .021 .000 
65.0000 .000 .000 
         
    The test result variable(s): TOTALSOFA has at least one tie between 
the positive actual state group and the negative actual state group. 
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        a. The smallest cutoff value is the minimum observed test value 
minus 1, and the largest cutoff value is the maximum observed test value 
plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
These data depict that a total SOFA score of 33 and above is an 
excellent predictor of mortality, above which the number of non survivors 
increase. 
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Outcome based on sex: 
Sex Survivors Non survivors Total 
Male 33 36 69 
Female 20 11 31 
Total 53 47 100 
 
 
 
 
Out of 69 male patients, 36 (52.2%) patients expired and out of 31 
female patients, 11(35.5%) patients expired. 
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0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
ventilated
 
91 
 
Survivors Non survivors
8 
45 
 
 
non ventilated
 
33 
14 
 
non survivors
survivors
  
92 
 
Statistical significance of outcomes related to need for mechanical 
ventilation: 
Chi-Square Tests 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 31.285
a
 1 .000   
Continuity Correction
b
 29.048 1 .000   
Likelihood Ratio 33.141 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear 
Association 
30.972 1 .000 
  
N of Valid Cases
b
 100     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 
19.27. 
     
 
Among the 41 patients ventilated 33 (80.5%) expired and among 
the 59 patients who did not require ventilator support 14 (23.7%) expired.  
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Outcome related to comorbidities: 
Two comorbid illness are taken in this study. The patients were 
categorised as having 
1) Diabetes 
2) Hypertension 
3) Both diabetes and hypertension 
4) Neither diabetes nor hypertension 
 
Comorbid illness survivors Non survivors 
Diabetes 15 9 
Hypertension 6 5 
Both DM and SHT 7 8 
Neither DM nor SHT 25 25 
 
  
  
Graphic representation:
 
Among the 47 non survivors, 9  are diabetics, 5 are hypertensives, 
8 are both diabetic and hypertensives, 25 are neither diabetic nor 
hypertensive. These comorbidities are not found to have any relationship 
with outcome in our study.
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Hypertension Both DM and 
SHT
Neither DM 
nor SHT
 
Non survivors
Survivors
 Outcomes in relation to socioeconomic status:
Socioeconomic status
High 
Low 
Total 
 
Socioeconomic status
 
0
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 Survivors Non survivors
32 24
21 23
53 47
 
 
Low
21
23
 
 
 
 
 
Non survivors
Survivors
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Chi-Square Tests: 
 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .877
a
 1 .349   
Continuity Correction
b
 .540 1 .463   
Likelihood Ratio .878 1 .349   
Fisher's Exact Test    .421 .231 
Linear-by-Linear 
Association 
.868 1 .351 
  
N of Valid Cases
b
 100     
 
 
Patients were segregated into low and high socioeconomic groups 
based on modified kuppusamy scale. Out of the 56 patients belonging to 
high socioeconomic group 24 (42.9%) expired. Out of the 44 patients in 
the low socioeconomic group 23(52.3%) expired. 
 
 
 
  
97 
 
                                         DISCUSSION 
Since the cost of health care is increasing day to day, assessment of 
a patient’s prognosis is vital during the course of treatment. Outcome 
prediction gains importance in this regard. So scoring systems have been 
used to predict this. SOFA scoring system, because of its simplicity and 
easy applicability, has been widely used in ICU setting. This system has 
also been evaluated in many ICUs and found to be useful as a simple 
bedside tool.  
In our study sex of the patient did not play a significant role in 
influencing mortality. The morbidity and mortality is purely related to the 
underlying disease state. 
 Also comorbidities like diabetes and hypertension did not 
influence the outcome much, since there is no much statistical 
significance. 
But, the need for mechanical ventilation clearly predicted mortality 
outcome since, the patients who were ventilated showed a higher 
mortality rate compared to those who did not require ventilator support, 
as evidenced by the statistically significant p value < 0.001. 
Patients belonging to low socioeconomic status showed higher 
mortality rate(52.3%) compared to their counterparts belonging to high 
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socioeconomic state(42.9%). Though the values are not statistically 
significant in our study, to prove the association. 
There is a significant increase in mortality rate when the SOFA 
score is above 12. There is a steep rise in the mortality curve at this value. 
Admission SOFA, 48 hours SOFA and 96 hours SOFA are all 
statistically significant with a p value < 0.001. 
Delta SOFA which is the difference in values over a period of time 
is also statistically significant in our study. There is a strong evidence 
that, patients whose delta SOFA values when increased from the previous 
value, there is a greater chance that the patient may succumb to his 
illness. 
Mean SOFA value also proved to be an independent predictor of 
mortality. A value of more than 11 showed a sharp rise in mortality. 
Total SOFA score is also statistically significant in predicting 
mortality, irrespective of the disease state. A total SOFA score of more 
than 33.5 is associated with increased mortality. 
In summary SOFA score is very useful in predicting mortality in 
critically ill patients, since there is a strong correlation between a rise in 
the score and mortality in all stages of admission. 
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                                 CONCLUSION 
• There is a strong association between rise in SOFA score and 
mortality. 
• Mechanically ventilated patients have a high risk of mortality 
compared to non ventilated patients. 
• There is no significant association between comorbidities like 
diabetes and hypertension with mortality outcome.  
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                          LIMITATIONS OF THE STUDY 
• Limited number of subjects involved in the study. A larger 
study population will give more precise results 
• Since the age group varies from 17 to 85, age may influence the 
outcome which is not considered in our study. 
• Only the scores were considered irrespective of the underlying 
disease. So the mortality outcome of individual disease has not 
been studied, which might also have influenced the outcome. 
• Furthermore, it is only a single centre study. The disease 
pattern and patient profile may vary across various geographic 
locations, which in turn may influence the outcome. 
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                                               PROFORMA 
SERIAL NO:                                                                      DATE:  
NAME:                                                                               AGE:  
SEX:         ADDRESS:  
OCCUPATION:  
DATE OF ADMISSION:   
COMPLAINTS: 
HISTORY: 
 DIABETES – 
 HYPERTENSION -    
 SMOKING –  
 ALCOHOL –  
CLINICAL EXAMINATION: 
PULSE: BLOOD PRESSURE:  GCS SCORE: 
INVESTIGATIONS: 
COMPLETE BLOOD COUNT: 
SERUM CREATININE: 
SERUM BILIRUBIN: 
ABG ANALYSIS: 
MECHANICAL VENTILATORY SUPPORT: YES/NO 
ADMISSION SOFA:  SOFA 48:   SOFA 96: 
CONDITION AT DISCHARGE: SURVIVOR/ NON SURVIVOR 
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CONSENT  FORM 
 
I hereby agree that, I include myself in the study- "A Study on 
Mortality Outcomes in ICU Patients with Sequential Organ Failure 
Assessment (SOFA) Score" conducted by Dr.santhakumar.R.P.S.P. I 
have been informed that i would not be facing any adverse health 
problems due to the study and this will not affect the nature of the 
treatment at any cost.  
I have also been informed about the investigations i will be 
undergoing during the study period and I have the right to withdraw from 
the research project, if i feel that i am not ok with the project, at any point 
of time and it will not affect my further treatment. I also agree to disclose 
the finding of the examinations protecting the privacy as it is essential to 
predict the outcome of the study. 
 
 
Name & Signature of the patient  Name & Signature of the relative       
Place: 
Date:       
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xg;g[jy;  gotk;; [ ; ;; [ ; ;; [ ; ; 
bgah; : 
ghypdk; :        taJ : 
Kfthp : 
 
 muR nfhit kUj;Jtf; fy;Y}hpapy; bghJ kUj;Jt 
Jiwapy; gl;l nkw;gog;g[ gapYk; khzth; rhe;jFkhh;; ;; ;; ;.R.P.S.P. 
mth;fs; nkw;bfhs;Sk;  "SOFA SCORE mst[nfhy; bfhz;L jPtpu 
rpfpr;ir gphpt[ nehahspfspd; ,wg;gpid fzpj;jy;" Fwpj;j 
Ma;tpy; bra;Kiw kw;Wk; midj;J tptu';fisa[k; nfl;Lf; 
bfhz;L vdJ re;njf';fis bjspt[g;gLj;jpf; bfhz;nld; 
vd;gij bjhptpj;Jf; bfhs;fpnwd;. 
 ehd; ,e;j Ma;tpy; KG rk;kjj;Jld;/ Ra rpe;jida[lDk; 
fye;J bfhs;s rk;kjpf;fpnwd;. 
 ,e;j Ma;tpy; vd;Dila midj;J tpgu';fs; 
ghJfhf;fg;gLtJld; ,jd; Kot[fs; Ma;tpjHpy; 
btspaplg;gLtjpy; Ml;nrgid ,y;iy vd;gij bjhptpj;Jf; 
bfhs;fpnwd;. ve;j neuj;jpYk; ,e;j Ma;tpypUe;J ehd; tpyfpf; 
bfhs;s vdf;F chpik cz;L vd;gija[k; mwpntd;. 
 
,lk;  :       ifbahg;gk; / nuif 
ehs; : 
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SOFA score: 
 
 0 1 2 3 4 
Respiration 
PaO2/FIO2 (mm 
Hg) 
SaO2/FIO2 
>400 <400 
221–301 
<300 
142–220 
<200 
67–141 
<100 
<67 
Coagulation 
Platelets 
10
3
/mm
3
 
>150 <150 <100 <50 <20 
Liver 
Bilirubin 
(mg/dL) 
<1.2 1.2–1.9 2.0–5.9 6.0–11.9 >12.0 
Cardiovascular
b
 
Hypotension 
No 
hypotension 
MAP <70 
Dopamine 
</=5 or 
dobutamin
e (any) 
 
Dopamine  
>5 or 
norepinephrine 
</=0.1 
Dopamine  
>15 or 
norepineph
rine 
>0.1 
CNS 
Glasgow Coma 
Score 
15 13–14 10–12 6–9 <6 
Renal 
Creatinine 
(mg/dL) or 
urine output 
(mL/d) 
<1.2 1.2–1.9 2.0–3.4 
3.5–4.9 or 
<500 
>5.0 or 
<200 
 
MAP - mean arterial pressure, CNS - central nervous system, SaO2- 
peripheral arterial oxygen saturation, 
a
PaO2/FIO2 ratio was used 
preferentially, If not available, the SaO2/FIO2 ratio was used; 
b
Vasoactive 
mediations administered for at least 1 hr (dopamine or norepinephrine 
ug/kg/min). 
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LIST OF ABBREVIATIONS 
 
ABG   –  Arterial blood gas analysis 
ACCF  –  American college of cardiology foundation 
AHA   - American heart association 
APACHE  –  Acute physiology and chronic health evaluation 
ARDS  –  Adult respiratory distress syndrome 
BEE   –  Basal energy expenditure 
CIM    -  Critical illness myopathy 
CIN   –  Critial illness neuropathy 
CIP   –  Critical illness polyneuropathy 
CMAP  –  Compound muscle action potential 
EMG   -   Electromyogram 
ESC   –  European society of cardiology 
ESPEN  –  European society for parenteral and enteral nutrition 
FiO2   –  Fraction of  inspired oxygen 
GBS   –  Guillain Barre Syndrome 
GCS   –  Glasgow coma scale 
ICU   –  Intensive care unit 
ICS   –  Intensive care society 
LBBB  –  Left bundle branch block 
LLN   –  Lower limit of normal 
LODS  –  Logistic organ dysfunction score 
MODS  –  Multi organ dysfunction score 
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MODS  –  Multi organ dysfunction syndrome 
MUPs  –  Motor unit potentials  
MPM  –  Mortality probability model 
NICE  –  National institute for health and clinical excellence 
PCI   –  Percutaneous coronary intervention 
PEEP   –  Positive end expiratory pressure 
r- tPA  –  Recombinant tissue plasminogen activator 
SIRS   –  Systemic inflammatory response syndrome 
SNAP  –  Sensory neuron action potential 
SOFA  –  Sequential organ failure assessment 
UTI   –  Urinary tract infection 
VILI   –  Ventilator induced lung injury 
WHF   –  World health federation 
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KEY TO MASTER CHART 
 
ARDS  –  Adult respiratory distress syndrome 
CVA   –  cerebrovascular accident 
CVT   –  cortical venous thrombosis 
COPD  –  chronic obstructive pulmonary disease 
OPC   –  organophosphorus poisoning 
 
Coding: 
A  –   Survivor 
B  –   Non survivor 
 
R1  –  Smoker 
R2  -   Alcoholic 
R3  –  Both smoker and alcoholic 
R4  –  Non smoker and non alcoholic 
 
1  -   Diabetic 
2  –  Hypertensive 
3  –  Both diabetic and hypertensive 
4  –  Non diabetic and non hypertensive 
 
X  –  High socioeconomic group 
Y  –  Low socioeconomic group 
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S.NO            Name AGE SEX               DIAGNOSIS
    COMORBID 
ILLNESS
VENTILATOR 
SUPPORT
SOFA SCORE ON 
ADMISSION
SOFA SCORE AT 
48 HOURS
SOFA SCORE 
AT 96 HOURS
RISK 
FACTORS
SOCIOECONOMIC 
STATUS OUTCOME
1 GANESH 60 M OPC POISONING 4 YES 9 11 15 R1 Y B
2 ARUKKANI 65 F SNAKE BITE 1 NO 6 6 4 R4 X A
3 MOOKAYEE 52 F CVA HEMORRHAGIC STROKE 2 YES 8 10 13 R4 X B
4 SELVAM 42 M CHRONIC KIDNEY DISEASE 3 NO 10 12 10 R3 X A
5 KARUPPAN 42 M CIRRHOSIS LIVER 4 NO 12 16 18 R2 Y B
6 LAKSHMI 68 F YELLOW DYE POISONING 1 YES 10 12 12 R4 X B
7 SUBBAN 23 M SNAKE BITE 4 YES 8 14 14 R4 X B
8 VADIVU 70 F MYOCARDIAL INFARCTION 3 YES 12 10 10 R4 Y A
9 KARTHIKEYAN 45 M CVA ISCHAEMIC STROKE 3 YES 13 15 15 R1 Y B
10 POONGODI 19 F ALUMINIUM PHOSPHIDE POISONING 1 NO 16 20 20 R4 X B
11 MUNIYAN 60 M CIRRHOSIS LIVER 1 NO 8 6 6 R3 Y A
12 MOOKANDI 59 M MYOCARDIAL INFARCTION 3 NO 8 4 4 R1 X A
13 LEELAVATHY 60 F MYOCARDIAL INFARCTION 2 YES 6 6 6 R4 X A
14 JENCY 52 F CHRONIC KIDNEY DISEASE 1 NO 8 10 10 R4 Y A
15 ALAGUMUTHU 75 M ULCER FOOT/SEPTICEMIA 1 NO 15 18 20 R1 X B
16 SURYAPRAKASH 36 M MYOCARDIAL INFARCTION 1 NO 8 6 6 R3 Y A
17 BASKAR 52 M CHRONIC KIDNEY DISEASE 1 NO 15 18 18 R2 Y B
18 BALAJI 61 M MYOCARDIAL INFARCTION 3 NO 12 10 10 R3 X A
19 SENTHIL 18 M SNAKE BITE 4 NO 10 6 6 R3 Y A
20 LATHA 70 F CVA HEMORRHAGIC STROKE 3 YES 8 10 10 R4 X B
21 BALU 48 M PARAQUAT POISONING 4 YES 8 14 20 R3 Y B
22 KALAI 19 F OPC POISONING 4 YES 12 16 16 R4 Y B
23 KARUNAISELVAN 32 M CIRRHOSIS LIVER 4 NO 10 8 8 R2 X A
24 MUTHU 23 M CIRRHOSIS LIVER 4 NO 12 10 9 R3 X A
25 KATHIRAVAN 50 M YELLOW DYE POISONING 4 NO 8 6 6 R4 Y A
MASTER CHART 
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26 KUMARESAN 65 M MYOCARDIAL INFARCTION 1 NO 12 10 10 R4 X B
27 DURAI 38 M OPC POISONING 4 NO 10 14 16 R3 Y B
28 RAJESHWARI 37 F CVA ISCHAEMIC STROKE 1 NO 8 10 8 R4 Y A
29 KAVITHA 35 F CHRONIC KIDNEY DISEASE 4 NO 11 10 10 R4 X A
30 JEEVA 23 F PYELONEPHRITIS 4 NO 14 12 12 R4 X A
31 RAJA 41 M CIRRHOSIS LIVER 4 NO 16 18 19 R3 Y B
32 SARAVANAN 50 M OPC POISONING 1 YES 15 20 20 R1 X B
33 GOWRISANKAR 68 M GANGRENE FOOT 1 YES 12 16 18 R3 X B
34 RAMU 17 M SNAKE BITE 4 NO 13 10 10 R4 Y A
35 BANGARU 46 F MYOCARDIAL INFARCTION 1 NO 15 12 12 R4 X A
36 KANAGARAJ 52 M CIRRHOSIS LIVER 4 YES 11 10 10 R2 X A
37 VENKATESH 35 M CVA HEMORRHAGIC STROKE 2 YES 11 15 15 R1 Y B
38 SUBBU 60 M MYOCARDIAL INFARCTION 3 NO 8 8 8 R3 Y A
39 KATHAYEE 55 F MYOCARDIAL INFARCTION 1 NO 8 10 8 R4 Y A
40 KUMARESAN 59 M CVA ISCHAEMIC STROKE 2 NO 12 10 10 R1 X A
41 IDUMBAN 48 M CIRRHOSIS LIVER 4 NO 8 6 6 R3 X A
42 SUKUMAR 35 M OPC POISONING 4 YES 12 10 12 R3 Y A
43 SAVEETHA 28 F CVT 4 YES 12 13 13 R4 X B
44 RAJASEKAR 35 M PNEUMONIA 1 YES 13 10 10 R1 X A
45 VINOTH 54 M CHRONIC KIDNEY DISEASE 2 YES 10 12 14 R3 Y B
46 SARAVANAN 25 M BACTERIAL MENINGITIS 4 NO 10 8 8 R2 X A
47 RAMESH 46 M CIRRHOSIS LIVER 4 YES 15 15 16 R1 Y B
48 RAHUMAN 70 M MYOCARDIAL INFARCTION 3 NO 13 14 14 R4 X B
49 KATHEEJA 36 F OPC POISONING 4 YES 13 14 16 R4 X B
50 PRADEEP 50 M CVA ISCHAEMIC STROKE 2 NO 8 6 6 R3 Y A
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51 GUNASEKAR 60 M CVA HEMORRHAGIC STROKE 2 YES 12 16 16 R1 X B
52 SENBAHAM 38 F SNAKE BITE 4 NO 8 7 7 R4 X A
53 NATARAJAN 55 M PNEUMONIA 3 YES 14 16 17 R3 X B
54 SANGUMUTHU 40 M CHRONIC KIDNEY DISEASE 3 NO 10 9 8 R4 Y A
55 RAVISANKAR 52 M PARAQUAT POISONING 4 YES 16 16 18 R3 X B
56 GOVINDAN 66 M CVA HEMORRHAGIC STROKE 3 YES 13 12 12 R1 Y B
57 MANISHARMA 56 M CIRRHOSIS LIVER 4 YES 14 15 16 R3 Y B
58 GAYATHRI 60 F MYOCARDIAL INFARCTION 1 NO 11 10 10 R4 X A
59 SELVARAJ 46 M ALUMINIUM PHOSPHIDE POISONING 4 YES 16 19 20 R2 X B
60 SAROJA 63 F CHRONIC KIDNEY DISEASE 1 NO 13 10 10 R4 Y A
61 INBARAASU 72 M AORTIC DISSECTION 2 NO 8 8 9 R1 Y B
62 RASIMUTHU 46 M ASPIRATION PNEUMONIA 1 NO 8 6 6 R3 X A
63 KOTHAI 59 F TB MENINGITIS 4 YES 10 8 8 R4 Y A
64 ANBUMANI 61 M SNAKE BITE 4 NO 8 10 10 R2 X A
65 BALAMANI 63 F CIRRHOSIS LIVER 4 NO 12 12 10 R2 Y B
66 SUNDARAVEL 70 M OPC POISONING 4 YES 16 12 12 R2 Y B
67 PRAVEEN 19 M SICKLE CELL ANAEMIA 4 NO 8 7 7 R4 Y A
68 RAJAN 25 M MYOCARDIAL INFARCTION 4 NO 8 6 6 R3 X A
69 VIJAYSANKAR 30 M H1N1 PNEUMONIA 1 YES 12 16 16 R1 Y B
70 PRATHAP 66 M CHRONIC KIDNEY DISEASE 2 NO 7 10 9 R2 Y A
71 IRUTHAYAMARY 85 F COPD COR PULMONALE 4 YES 16 18 18 R4 X B
72 SATHISH 30 M PARAQUAT POISONING 4 YES 20 22 22 R3 Y B
73 KATHAMUTHU 64 M PULMONARY TB 1 NO 10 6 6 R1 X A
74 LAXMIPRIYA 67 F DIABETIC KETOACIDOSIS 1 NO 16 12 12 R4 X A
75 GEETHAMATHI 47 F ARDS/SEPSIS 4 YES 20 18 18 R2 X B
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76 SANTHOSH 56 M CIRRHOSIS LIVER 4 N0 16 18 18 R3 Y B
77 PRIYA 18 F OLEANDER SEED POISONING 4 NO 6 6 6 R4 Y A
78 GOMATHI 60 F DIABETES MELLITUS/SEPTICEMIA 1 NO 12 14 14 R4 Y A
79 JAMESON 50 M AIDP - GUILLAIN BARRE SYNDROME 4 YES 18 16 16 R4 X B
80 PANDIYAN 40 M PNEUMOTHORAX 4 NO 10 8 8 R1 X A
81 RAJARATHINAM 75 M SUBARACHNOID HEMORRHAGE 3 YES 12 14 16 R3 Y B
82 KUMARAVEL 64 M CAHD/CARDIAC FAILURE 2 NO 13 12 12 R3 X A
83 THANGARAJ 44 M CIRRHOSIS LIVER/HEPATIC ENCEPHALOPATHY4 NO 13 16 18 R2 X B
84 XAVIER 50 M SEIZURE DISORDER 4 YES 12 12 8 R4 X A
85 ELANGO 28 M ACID POISONING 4 NO 8 8 6 R3 X A
86 PALANI 17 M BACTERIAL MENINGITIS 4 YES 14 14 16 R1 Y B
87 MARUTHACHALAM 35 M PULMONARY EMBOLISM 4 YES 8 8 8 R2 X B
88 MARIMUTHU 35 M ARDS/SEPSIS 4 NO 13 13 12 R3 Y B
89 KRISHNAKUMAR 70 M SNAKE BITE 3 YES 6 8 9 R4 X B
90 HASEENA 40 F RHEUMATIC HEART DISEASE 4 YES 12 12 13 R4 X B
91 BOMMAN 60 M ACUTE MYELOID LEUKEMIA 1 NO 14 12 12 R4 X A
92 ANBUSELVI 28 F ACUTE LYMPHOBLASTIC LEUKEMIA 4 NO 8 6 6 R4 Y A
93 SAKTHIVEL 35 M ACUTE ALCOHOL INTOXICATION 4 NO 10 10 9 R3 Y A
94 SELVAMUTHU 45 M DIABETIC KETOACIDOSIS 1 YES 13 12 13 R4 X B
95 MANIMEKALAI 55 F COPD COR PULMONALE 2 NO 9 10 10 R4 X A
96 AISHA BANU 52 F BRONCHIAL ASTHMA 3 YES 14 13 13 R4 X A
97 KARUNAIKATHIR 18 M OPC POISONING 4 NO 10 12 13 R3 X A
98 MUTHUKARUPPAN 72 M CARCINOMA LUNG 3 NO 16 16 18 R1 Y B
99 KALAISELVI 25 F HERBICIDE POISONING 4 NO 6 7 7 R4 X A
100 MATHIYAAS 45 M PLEURAL EFFUSION 4 NO 8 8 7 R1 X A
